首页--农业科学论文--畜牧、动物医学、狩猎、蚕、蜂论文--动物医学(兽医学)论文--各种家畜、家禽、野生动物的疾论文--家禽论文--鸡论文

Hsp90抑制剂对福美双诱导的胫骨软骨发育不良肉鸡生长板血管生成的影响

摘要第9-11页
ABSTRACT第11-13页
CHAPTER 1 Introduction第15-28页
    1.1 Endochodreal Ossification第15-16页
    1.2 Epiphyseal plate or Growth plate第16-17页
    1.3 Chicken Growth Plate第17-20页
    1.4 Tibial Dyschondroplasia第20-22页
    1.5 Heat Shock Protein 90 (Hsp90)第22-23页
    1.6 Role of Hsp90 in Angiogenesis第23-24页
    1.7 Discovery of Hsp90 inhibitors and Hsp90 inhibition in TD research第24-27页
        1.7.1 Celastrol第25页
        1.7.2 Gambogic Acid第25-26页
        1.7.3 Novobiocin第26-27页
    1.8 Conclusion and Hypothesis第27-28页
CHAPTER 2 Hsp90 inhibitor celastrol reinstates growth plate angiogenesis in thiram-induced tibialdyschondroplasia第28-39页
    2.1 Objectives第28页
    2.2 Materials and Methods第28-31页
        2.2.1 Experimental birds第28页
        2.2.2 Celastrol preparation第28页
        2.2.3 Establishment and treatment of thiram-induced TD第28-29页
        2.2.4 Hematoxylin & Eosin (H&E) staining第29页
        2.2.5 RNA extraction and reverse transcription第29页
        2.2.6 Reverse transcription quantitative-real time PCR (RT-qPCR)第29-30页
        2.2.7 Western blot analysis第30-31页
        2.2.8 Statistical Analysis第31页
    2.3 Results第31-36页
        2.3.1 Effect of Celastrol on thiram-induced TD affected birds第31-33页
        2.3.2 Morphometric analysis of growth plate第33-34页
        2.3.3 Hsp90 level in TD affected growth plates correlated with the inhibitory effect ofcelastrol第34页
        2.3.4 VEGF and Flk-1 receptor level in TD affected growth plates第34-36页
    2.4 Discussion第36-39页
CHAPTER 3 Hsp90 inhibitor celastrol attenuate liver damage caused by thiram第39-43页
    3.1 Objectives第39页
    3.2 Materials and Methods第39-40页
        3.2.1 Animal selection & ethics第39页
        3.2.2 Experimental design and induction of TD第39-40页
        3.2.3 Blood serum biomarkers assay.第40页
        3.2.4 Liver tissue sample collection and antioxidant determination第40页
        3.2.5 Statistical analysis第40页
    3.3 Results第40-41页
    3.4 Discussion第41-43页
CHAPTER 4 Gambogic Acid Inhibits Hsp90 Expressions and restored the growth plate width in Thiram-Induced Tibial Dyschondroplasia第43-50页
    4.1Objectives第43页
    4.2 Materials and Methods第43-45页
        4.2.1 Animal welfare & ethics第43页
        4.2.2 Experimental design and bird?s selection第43-44页
        4.2.3 Birds slaughtering and sample collection第44页
        4.2.4 Quantitave real time polymerase chain reaction第44页
        4.2.5 Liver antioxidant enzyme sampling第44-45页
        4.2.6 Statistical analysis第45页
    4.3 Results第45-47页
        4.3.1 Effects of Hsp90 inhibition on growth plate size with GA第45页
        4.3.2 Hsp90 expressions before and after GA administration in thiram induced TD第45-46页
        4.3.3 Liver antioxidant activities in thiram fed birds and gambogic acid treatment第46-47页
    4.4 Discussion第47-50页
CHAPTER 5 Novobiocin Ameliorate Tibial Dyschondroplasia through Inhibition of Hsp-90 Expressions inAvian Growth Plate第50-63页
    5.1 Objectives第50页
    5.2 Materials and Methods第50-52页
        5.2.1 Animal ethics and welfare第50页
        5.2.2 Induction and evaluation of disease第50页
        5.2.3 Birds slaughtering and tissue extraction第50-51页
        5.2.4 RNA extraction and reverse transcription第51页
        5.2.5 Reverse transcription quantitative-real time PCR (RT-qPCR)第51页
        5.2.6 Immunohistochemistry (IHC) and Hematoxylin & Eosin (H&E) staining第51-52页
        5.2.7 Western blot analysis第52页
        5.2.8 Statistical analysis第52页
    5.3 Results第52-59页
        5.3.1 Morphological examination of growth plate from TD affected and Novobiocintreated group第52-53页
        5.3.2 Histological features of growth plate (GP)第53-55页
        5.3.3 Inhibitory effect of Novobiocin on Hsp90 level in TD affected growth plates第55-57页
        5.3.4 Immunohistochemical evaluation of epiphyseal growth plate第57-58页
        5.3.5 Differential expression of proteoglycan aggrecan in growth plate第58-59页
    5.4 Discussions第59-63页
CHAPTER 6第63-65页
    6.1 Conclusion第63-64页
        6.1.1 Study I第63页
        6.1.2 Study II第63页
        6.1.3 Study III第63-64页
        6.1.4 Study IV第64页
    6.2 Future Prospects第64-65页
References第65-75页
List of Figures第75-76页
Lists of Tables第76-77页
Acknowledgements第77-79页
Appendix I第79-81页
    Publications第79-81页

论文共81页,点击 下载论文
上一篇:原发性IgA肾病的临床病理特点及少量蛋白尿型IgA肾病的预后与治疗分析
下一篇:理想生成的格上粗集及格值粗集的研究